Influence of flumequine on in vivo mitogen responses of European eel (Anguilla anguilla L., 1758) lymphoid cells.
The influence of flumequine on mitogen induced lymphoid cell proliferation in European eels (Anguilla anguilla L., 1758) was studied. For this purpose an in vivo test, using peroral drug administration followed by successive intraperitoneal injections with concanavalin A (ConA) or bacterial lipopolysaccharides (LPS) and 5-bromo-2'-deoxyuridine, was applied. Direct counting of proliferated cells in blood smears revealed that flumequine possesses mitogenic properties. A synergistic and an antagonistic effect of the drug was observed after LPS and ConA stimulation, respectively. Flow cytometric analysis of peripheral blood lymphoid cells showed a significant reduction of the mean proportion surface immunoglobulin positive cells in the flumequine-treated animals. It is concluded that flumequine enhances proliferation of lymphoid cells (probably surface immunoglobulin negative cells) in eel under the present experimental conditions.
van der Heijden
M H
MH
Department of Fish Culture and Fisheries, Wageningen Agricultural University, Netherlands.
Booms
G H
GH
Tanck
M W
MW
Rombout
J H
JH
Boon
J H
JH
D000818:Animals; D000890:Anti-Infective Agents / Q000494:pharmacology*; D000963:Antimetabolites / Q000494:pharmacology; D017756:Aquaculture; D001402:B-Lymphocytes / Q000187:drug effects* / Q000276:immunology; D001973:Bromodeoxyuridine / Q000494:pharmacology; D003208:Concanavalin A / Q000494:pharmacology; D004247:DNA / Q000096:biosynthesis; D004261:DNA Replication / Q000187:drug effects; D004524:Eels / Q000276:immunology*; D005260:Female; D005434:Flow Cytometry / Q000662:veterinary; D024841:Fluoroquinolones; D007150:Immunohistochemistry; D008070:Lipopolysaccharides / Q000494:pharmacology; D008213:Lymphocyte Activation / Q000187:drug effects; D008297:Male; D011807:Quinolizines / Q000494:pharmacology*; D011897:Random Allocation; D013601:T-Lymphocytes / Q000187:drug effects* / Q000276:immunology
D000890:Anti-Infective Agents; D000963:Antimetabolites; D024841:Fluoroquinolones; D008070:Lipopolysaccharides; D011807:Quinolizines; D003208:Concanavalin A; D004247:DNA; D001973:Bromodeoxyuridine; C012976:flumequine